A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction (MI) and preserved left ventricular ejection fraction (LVEF) found this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback